Overview

Effects of Coenzyme Q10 in PSP and CBD

Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy, safety and tolerability of Coenzyme Q 10 versus placebo in patients with atypical parkinsonian syndromes corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) ).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Lahey Clinic
Treatments:
Coenzyme Q10
Ubiquinone